scispace - formally typeset
S

Stephen L. Bacharach

Researcher at University of California, San Francisco

Publications -  212
Citations -  17008

Stephen L. Bacharach is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Ejection fraction & Coronary artery disease. The author has an hindex of 67, co-authored 212 publications receiving 16453 citations. Previous affiliations of Stephen L. Bacharach include Institut Gustave Roussy & National Institutes of Health.

Papers
More filters
Journal ArticleDOI

Partial-Volume Effect in PET Tumor Imaging

TL;DR: What PVE is and its consequences in PET tumor imaging are described; the parameters on which PVE depends are reviewed; and actions that can be taken to reduce the errors attributable to PVE are described.
Journal ArticleDOI

Profound but Reversible Myocardial Depression in Patients with Septic Shock

TL;DR: To characterize the role of cardiac function in septic shock, serial radionuclide cineangiographic and hemodynamic evaluations were done on 20 patients with documented septicShock, finding that nonsurvivors had normal initial ejection fractions and ventricular volumes that did not change during serial studies.
Journal ArticleDOI

Real-time radionuclide cineangiography in the noninvasive evaluation of global and regional left ventricular function at rest and during exercise in patients with coronary-artery disease.

TL;DR: In this paper, the authors developed a noninvasive real-time radionuclide cineangiographic procedure permitting continuous monitoring and analysis of left ventricular function during exercise.
Journal ArticleDOI

Impaired left ventricular diastolic filling in patients with coronary artery disease: assessment with radionuclide angiography.

TL;DR: LV diastolic filling, evaluated noninvasively by radionuclide angiography, is abnormal in a high percentage of patients with CAD at rest independent of LV systolic function or previous myocardial infarction.
Journal ArticleDOI

Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose.

TL;DR: Thallium imaging can be used to identify viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction and most irreversible defects with only mild or moderate reduction in thallium activity represent viableMyocardium as confirmed by FDG uptake.